logo
  Home | Contact us | Browse | Quick Search by UniProtKB ID, Keyword, PDBID

Menu:

Latest news:

Sep. 10, 2014:
A total of 174 experimentally verified S-nitrosylation sites on 94 S-nitrosylated proteins from individualized human colorectal cancer tissues using a label-free quantitation strategy.

Read more...


Protein Name: Elongation factor 2

UniprotKB/SwissProt ID: EF2_MOUSE (P58252)

Gene Name: Eef2

Organism: Mus musculus (Mouse).

Function: Catalyzes the GTP-dependent ribosomal translocation step during translation elongation. During this step, the ribosome changes from the pre-translocational (PRE) to the post- translocational (POST) state as the newly formed A-site-bound peptidyl-tRNA and P-site-bound deacylated tRNA move to the P and E sites, respectively. Catalyzes the coordinated movement of the two tRNA molecules, the mRNA and conformational changes in the ribosome.

Other Modifications: View all modification sites in dbPTM

Protein Subcellular Localization: Cytoplasm.

Graphical Visualization of S-nitrosylation Sites:
Overview of Protein S-nitrosylation Sites with Functional and Structural Information
InterPro ID Domain
IPR000640
IPR000795
IPR004161
IPR005225
IPR005517
IPR009000
IPR009022
IPR014721

The S-nitrosylation sites of EF2_MOUSE

No. Position S-nitrosylated Peptide Secondary Structure of S-nitrosylated Peptide Solvent Accessibility of nitrosylated Site Substrate Motifs PubMed ID Experiment
141GKSTLTDSLV C KAGIIASARA CHHHHHHHHH H HHCCCCHHHC 2.79%MC0324895380-
241GKSTLTDSLV C KAGIIASARA CHHHHHHHHH H HHCCCCHHHC 2.79%MC0319101475-
341GKSTLTDSLV C KAGIIASARA CHHHHHHHHH H HHCCCCHHHC 2.79%MC0320925432in vivo
441GKSTLTDSLV C KAGIIASARA CHHHHHHHHH H HHCCCCHHHC 2.79%MC0321278135in vitro
541GKSTLTDSLV C KAGIIASARA CHHHHHHHHH H HHCCCCHHHC 2.79%MC0320837516in vivo
641GKSTLTDSLV C KAGIIASARA CHHHHHHHHH H HHCCCCHHHC 2.79%MC0322865876in vivo
7290PDGKKLPRTF C QLILDPIFKV CCHHHHHHHH H HHHHCCHHHH 2.96%MC0122588120-
8290PDGKKLPRTF C QLILDPIFKV CCHHHHHHHH H HHHHCCHHHH 2.96%MC0120925432in vivo
9290PDGKKLPRTF C QLILDPIFKV CCHHHHHHHH H HHHHCCHHHH 2.96%MC0121278135in vitro
10290PDGKKLPRTF C QLILDPIFKV CCHHHHHHHH H HHHHCCHHHH 2.96%MC0120837516in vivo
11369PSPVTAQKYR C ELLYEGPPDD CCCCCCCCCC C CCCCCCCCCC 3.81%MC1320925432in vivo
12369PSPVTAQKYR C ELLYEGPPDD CCCCCCCCCC C CCCCCCCCCC 3.81%MC1321278135in vitro
13369PSPVTAQKYR C ELLYEGPPDD CCCCCCCCCC C CCCCCCCCCC 3.81%MC1320837516in vivo
14369PSPVTAQKYR C ELLYEGPPDD CCCCCCCCCC C CCCCCCCCCC 3.81%MC1322865876in vivo
15466RYVEPIEDVP C GNIVGLVGVD CCEEEEEEEC C CCEEEEEECC 7.00%MC1321278135in vitro
16466RYVEPIEDVP C GNIVGLVGVD CCEEEEEEEC C CCEEEEEECC 7.00%MC1322865876in vivo
17567CLKDLEEDHA C IPIKKSDPVV HHHHHHHHHC C EEEEECCCEE 3.22%MC0420925432in vivo
18567CLKDLEEDHA C IPIKKSDPVV HHHHHHHHHC C EEEEECCCEE 3.22%MC0421278135in vitro
19567CLKDLEEDHA C IPIKKSDPVV HHHHHHHHHC C EEEEECCCEE 3.22%MC0420837516in vivo
20591ETVSEESNVL C LSKSPNKHNR EEECCCCEEE E ECCCCCCCCE 3.34%MC0524895380-
21591ETVSEESNVL C LSKSPNKHNR EEECCCCEEE E ECCCCCCCCE 3.34%MC0521278135in vitro
22651WDVAEARKIW C FGPDGTGPNI CCCCCCCCEE E ECCCCCCCEE 3.00%MC1020925432in vivo
23651WDVAEARKIW C FGPDGTGPNI CCCCCCCCEE E ECCCCCCCEE 3.00%MC1021278135in vitro
24693FQWATKEGAL C EENMRGVRFD HHHHHHCCCE E CCCCCCEEEE 6.46%MC0424926564-
25693FQWATKEGAL C EENMRGVRFD HHHHHHCCCE E CCCCCCEEEE 6.46%MC0421278135in vitro
26728GGQIIPTARR C LYASVLTAQP HHHHHHHHHH H HHHHHHHCCC 2.58%MC0921278135in vitro
27728GGQIIPTARR C LYASVLTAQP HHHHHHHHHH H HHHHHHHCCC 2.58%MC0920837516in vivo
28728GGQIIPTARR C LYASVLTAQP HHHHHHHHHH H HHHHHHHCCC 2.58%MC0922865876in vivo
29751MEPIYLVEIQ C PEQVVGGIYG EEEEEEEEEE C CHHHHCHHHH 5.00%MC1321278135in vitro
30751MEPIYLVEIQ C PEQVVGGIYG EEEEEEEEEE C CHHHHCHHHH 5.00%MC1322865876in vivo